Heterogeneous genetic and non‐genetic mechanisms contribute to response and resistance to azacitidine monotherapy

Authors: Vasiliki Symeonidou, Marlen Metzner, Batchimeg Usukhbayar, Aimee E. Jackson, Sonia Fox, Charles F. Craddock, Paresh Vyas

Source: eJHaem, Vol 3, Iss 3, Pp 794-803 (2022)

Subject Terms: acute myeloid leukaemia, azacitidine, clonal evolution, hypomethylating agents, immune microenvironment, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2688-6146

Access URL: https://doaj.org/article/0ec7692b03e049f3a63341778660afdb